Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
CC

CC - Chemours Co-The Stock Price, Fair Value and News

24.38USD-1.18 (-4.62%)Market Closed

Market Summary

CC
USD24.38-1.18
Market Closed
-4.62%

CC Alerts

  • Big fall in Revenue (Y/Y)
  • Big fall in earnings (Y/Y)

CC Stock Price

View Fullscreen

CC RSI Chart

CC Valuation

Market Cap

3.8B

Price/Earnings (Trailing)

-11.53

Price/Sales (Trailing)

0.65

EV/EBITDA

67.57

Price/Free Cashflow

422.86

CC Price/Sales (Trailing)

CC Profitability

EBT Margin

-7.26%

Return on Equity

-43.88%

Return on Assets

-4.14%

Free Cashflow Yield

0.24%

CC Fundamentals

CC Revenue

Revenue (TTM)

5.8B

Rev. Growth (Yr)

-12.11%

Rev. Growth (Qtr)

-0.81%

CC Earnings

Earnings (TTM)

-330.0M

Earnings Growth (Yr)

-64.14%

Earnings Growth (Qtr)

388.89%

Breaking Down CC Revenue

Last 7 days

7.0%

Last 30 days

-11.7%

Last 90 days

-5.8%

Trailing 12 Months

-22.8%

How does CC drawdown profile look like?

CC Financial Health

Current Ratio

1.61

Debt/Equity

5.28

Debt/Cashflow

0.1

CC Investor Care

Dividend Yield

3.91%

Dividend/Share (TTM)

1

Buy Backs (1Y)

0.17%

Diluted EPS (TTM)

-2.22

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20245.8B000
20236.6B6.3B6.0B6.0B
20226.7B6.9B7.0B6.8B
20215.1B5.7B6.1B6.3B
20205.5B5.1B5.0B5.0B
20196.3B5.9B5.6B5.5B
20186.5B6.7B6.7B6.6B
20175.5B5.7B5.9B6.2B
20165.7B5.5B5.4B5.4B
20156.2B6.1B5.9B5.7B
20146.8B6.6B6.5B6.4B
20130006.9B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Chemours Co-The

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
May 08, 2024
dignam denise
acquired
-
-
34,431
president & ceo
May 08, 2024
familiar calderon gerardo
acquired
-
-
5,909
pres advanced performance mat
May 08, 2024
abbott matthew s
acquired
-
-
11,818
interim cfo
May 08, 2024
charles ron christopher
acquired
-
-
4,545
senior vice president, people
May 08, 2024
picho diane i.
acquired
-
-
7,272
interim pres. - titanium tech
May 08, 2024
fletcher pamela
acquired
-
-
1,454
-
May 08, 2024
martinko joseph t.
acquired
-
-
5,909
president, thermal & specializ
May 08, 2024
wellman kristine m
acquired
-
-
7,727
svp, gc & corp. secretary
May 08, 2024
scarborough alvenia
acquired
-
-
2,954
svp corp communications & cbo
Mar 27, 2024
dignam denise
acquired
-
-
9,496
president & ceo

1–10 of 50

Which funds bought or sold CC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jun 11, 2024
EverSource Wealth Advisors, LLC
added
6.06
-617
5,628
-%
Jun 04, 2024
Aurora Investment Counsel
reduced
-3.51
-61,511
346,921
0.20%
Jun 04, 2024
DekaBank Deutsche Girozentrale
sold off
-100
-33,000
-
-%
May 30, 2024
CAMBRIDGE TRUST CO
unchanged
-
-634
3,151
-%
May 28, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
-275,000
1,368,000
0.01%
May 24, 2024
Invst, LLC
sold off
-100
-539,129
-
-%
May 24, 2024
Northwest Bank & Trust Co
unchanged
-
-48.00
267
-%
May 24, 2024
Cetera Investment Advisers
new
-
371,677
371,677
-%
May 22, 2024
BURNEY CO/
added
0.31
-1,021,440
5,174,440
0.20%
May 22, 2024
Livelsberger Financial Advisory
sold off
-100
-1,924
-
-%

1–10 of 43

Are Funds Buying or Selling CC?

Are funds buying CC calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CC
No. of Funds

Unveiling Chemours Co-The's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
10.80%
16,028,054
SC 13G/A
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Jan 24, 2024
blackrock inc.
11.1%
16,512,174
SC 13G/A
Apr 10, 2023
fmr llc
-
0
SC 13G/A
Feb 14, 2023
sessa capital (master), l.p.
0.36%
547,057
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
12.20%
18,416,153
SC 13G/A
Jan 26, 2023
blackrock inc.
12.3%
18,516,903
SC 13G/A
Jan 20, 2023
blackrock inc.
12.3%
18,516,903
SC 13G/A
Apr 08, 2022
blackrock inc.
11.3%
18,075,740
SC 13G/A

Recent SEC filings of Chemours Co-The

View All Filings
Date Filed Form Type Document
Jun 13, 2024
8-K
Current Report
Jun 05, 2024
8-K
Current Report
Jun 03, 2024
8-K
Current Report
May 30, 2024
SD
SD
May 23, 2024
8-K
Current Report
May 10, 2024
4
Insider Trading
May 10, 2024
4
Insider Trading
May 10, 2024
4
Insider Trading
May 10, 2024
4
Insider Trading
May 10, 2024
4
Insider Trading

Peers (Alternatives to Chemours Co-The)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
63.5B
12.2B
14.77% -1.24%
25.7
5.22
-7.47% 13.44%
39.5B
43.5B
-6.05% 6.12%
31.11
0.91
-18.61% -57.39%
15.7B
10.7B
-9.77% 23.85%
7.91
1.47
7.11% 34.19%
15.0B
6.9B
-12.31% 12.58%
57.53
2.18
-6.48% -57.90%
12.7B
8.4B
-20.09% -52.19%
37.71
1.51
-4.27% -90.82%
12.1B
9.1B
1.83% 25.13%
13.05
1.32
-11.38% 33.67%
MID-CAP
5.5B
3.9B
-1.79% 35.81%
12.2
1.42
-8.19% 40.43%
4.9B
929.6M
-1.90% 12.99%
43.01
5.31
-1.74% 15.81%
4.0B
3.1B
-3.33% 10.37%
37.94
1.28
-6.69% -83.51%
2.9B
3.0B
1.09% 44.72%
8.92
0.97
-20.68% -74.38%
SMALL-CAP
1.2B
404.0M
0.11% 32.60%
36.59
3
24.06% -25.72%
642.6M
1.5B
-4.27% -31.94%
282.7
0.44
-21.27% -97.94%
152.4M
336.4M
-12.46% -14.18%
8.36
0.45
-12.92% 28.47%
57.3M
16.7M
-44.36% -56.98%
-3.83
3.42
-57.58% -734.07%
3.7M
-
-80.00% -99.58%
-0.01
0.01
- -

Chemours Co-The News

Latest updates
Defense World12 Jun 202412:56 pm
Reuters2 years ago
Yahoo Singapore News7 years ago

Chemours Co-The Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-0.8%1,3501,3611,4871,6431,5361,3381,7771,9151,7641,5751,6801,6551,4361,3381,2331,0931,3051,3531,3901,4081,376
Gross Profit12.2%286255273410368202432497486393427264297313257199298150294323296
Operating Expenses-33.2%174261319806166211171280182190154204158250143147160183184162186
  S&GA Expenses-36.2%142223165779124175140254141158124172139180112110125126130136156
  R&D Expenses7.7%28.0026.0028.0028.0026.0031.0032.0025.0030.0029.0027.0027.0024.0027.0022.0020.0024.0019.0020.0019.0022.00
EBITDA Margin-45.5%0.02*0.03*0.03*0.07*0.17*0.18*0.22*0.22*0.20*0.19*0.15*0.13*---------
Interest Expenses0%63.0063.0055.0048.0042.0041.0041.0040.0041.0044.0045.0047.0049.0050.0053.0053.0054.0052.0053.0052.0051.00
Income Taxes128.3%15.00-53.001.00-57.0028.0028.0059.0030.0046.0069.0017.00-22.005.004.00-16.00-4.00-23.00-13715.0037.0013.00
Earnings Before Taxes194.4%67.00-71.0013.00-433173-69.0029923128030123144.0010123.0060.0020.0077.00-45491.00133107
EBT Margin-37.6%-0.07*-0.05*-0.05*0.00*0.10*0.11*0.16*0.15*0.13*0.11*0.07*0.04*---------
Net Income388.9%52.00-18.0012.00-376145-97.0024020123423321466.0096.0019.0076.0024.00100-31776.0096.0094.00
Net Income Margin-43.7%-0.06*-0.04*-0.05*-0.01*0.07*0.09*0.13*0.13*0.11*0.10*0.06*0.05*---------
Free Cashflow-213.0%-39234745.009.00-21594.00229229-104125244189---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-3.3%7,9788,2517,9487,6607,6247,6407,7457,7307,5247,5507,5307,4797,1707,0826,9487,0346,9487,2587,4567,4337,325
  Current Assets-6.2%3,5973,8353,6833,3743,2023,2143,5433,6063,3933,3453,3713,0472,7862,6332,6052,7172,5912,7772,8272,8322,847
    Cash Equivalents-38.0%7461,2038527381,0211,3041,3681,3481,2451,4511,1311,1391,0081,1059561,031714943694630697
  Inventory2.9%1,3911,3521,3141,4461,4861,4041,3211,2191,1661,0991,0161,0469889399931,0741,1141,0791,2231,2501,218
  Net PPE-0.2%3,2093,2163,1193,1903,1803,1713,0713,1113,1313,1543,1273,4483,4323,4743,4183,4233,4443,5593,5203,4913,379
  Goodwill0%102102102102102102102102102102102153152153---153---
Liabilities-3.8%7,2247,5127,1996,8506,3966,5336,4606,5156,3576,4686,5316,5796,3186,2676,2146,3756,2876,5636,6136,6046,509
  Current Liabilities-10.3%2,2312,4862,9252,1901,7451,8911,9511,8861,7751,8581,7791,6741,5011,4421,3081,1561,3431,5411,6431,4481,572
  Long Term Debt-0.5%3,9683,9873,9443,6043,5993,5903,5103,6563,6923,7243,8293,9643,9704,0054,0634,3274,0124,0264,0074,1903,965
    LT Debt, Current--------------------18.0013.00
    LT Debt, Non Current-0.5%3,9683,9873,9443,6043,5993,5903,5103,6563,6923,7243,8293,9643,9704,0054,0634,3274,0124,0264,0074,1903,965
Shareholder's Equity2.0%7527377498101,2281,1071,2851,2151,1671,082999900852815734659661695843829816
  Retained Earnings0.8%1,7971,7821,8371,8642,2782,1702,3042,1021,9401,7461,5541,3811,3571,3031,3251,2901,3081,2491,6061,5711,517
  Additional Paid-In Capital0%1,0331,0331,0301,0141,0041,0161,0151,005956944926920907890879872870859857853845
Accumulated Depreciation1.0%6,2606,1966,1246,3586,3196,2166,1156,1536,1236,0786,0806,2206,1216,1085,9735,8735,7705,8545,7545,7685,710
Shares Outstanding0.1%149149148148149149153156157161164165---------
Minority Interest0%2.002.002.002.001.00-1.001.001.001.001.002.002.002.002.002.006.006.006.006.006.00
Float----5,500---5,000---5,700---2,500---3,900-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-160.2%-290,000482,000131,00067,000-124,000161,000301,000291,0002,000208,000311,000256,00039,000353,000299,000111,00044,000400,000288,0006,000-44,000
  Share Based Compensation-80.0%1,0005,0006,0003,0004,0003,0007,0007,00010,00010,0004,0008,00012,0004,0003,0001,0008,0001,0004,0006,0008,000
Cashflow From Investing22.3%-101,000-130,00058,000-60,000-97,000-65,000-74,000-35,000-110,000422,000-68,000-57,000-77,000-34,000-37,000-51,000-112,000-96,000-131,000-122,000-134,000
Cashflow From Financing-980.0%-54,000-5,000324,000-79,000-68,000-191,000-175,000-131,000-189,000-195,000-241,000-76,000-42,000-187,000-354,000247,000-155,000-59,000-77,00041,000-324,000
  Dividend Payments0%37,00037,00037,00038,00037,00037,00039,00038,00040,00041,00041,00041,00041,00041,00041,00041,00041,00040,00041,00041,00042,000
  Buy Backs---18,00037,00014,000144,00079,000128,000144,00093,00067,00013,000-------67,000255,000
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

CC Income Statement

2024-03-31
Interim Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Net sales$ 1,350$ 1,536
Cost of goods sold1,0641,168
Gross profit286368
Selling, general, and administrative expense142124
Research and development expense2826
Restructuring, asset-related, and other charges416
Total other operating expenses174166
Equity in earnings of affiliates1312
Interest expense, net(63)(42)
Other income, net51
Income before income taxes67173
Provision for income taxes1528
Net income52145
Net income attributable to Chemours$ 52$ 145
Per share data  
Basic earnings per share of common stock$ 0.35$ 0.97
Diluted earnings per share of common stock$ 0.34$ 0.96

CC Balance Sheet

2024-03-31
Interim Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 746$ 1,203
Restricted cash and restricted cash equivalents607604
Accounts and notes receivable, net792610
Inventories1,3911,352
Prepaid expenses and other6166
Total current assets3,5973,835
Property, plant, and equipment9,4699,412
Less: Accumulated depreciation(6,260)(6,196)
Property, plant, and equipment, net3,2093,216
Operating lease right-of-use assets252260
Goodwill102102
Other intangible assets, net33
Investments in affiliates165158
Other assets650677
Total assets7,9788,251
Current liabilities:  
Accounts payable9631,159
Compensation and other employee-related cost7989
Short-term and current maturities of long-term debt4151
Current environmental remediation129129
Other accrued liabilities1,0191,058
Total current liabilities2,2312,486
Long-term debt, net3,9683,987
Operating lease liabilities198206
Long-term environmental remediation452461
Deferred income taxes4444
Other liabilities331328
Total liabilities7,2247,512
Commitments and contingent liabilities
Equity  
Common stock (par value $0.01 per share; 810,000,000 shares authorized; 197,711,836 shares issued and 148,779,449 shares outstanding at March 31, 2024; 197,519,784 shares issued and 148,587,397 shares outstanding at December 31, 2023)22
Treasury stock, at cost (48,932,387 shares at March 31, 2024 and December 31, 2023)(1,806)(1,806)
Additional paid-in capital1,0331,033
Retained earnings1,7971,782
Accumulated other comprehensive loss(274)(274)
Total Chemours stockholders’ equity752737
Non-controlling interests22
Total equity754739
Total liabilities and equity$ 7,978$ 8,251
CC
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and other applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
 CEO
 WEBSITEchemours.com
 INDUSTRYChemicals
 EMPLOYEES6600

Chemours Co-The Frequently Asked Questions


What is the ticker symbol for Chemours Co-The? What does CC stand for in stocks?

CC is the stock ticker symbol of Chemours Co-The. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Chemours Co-The (CC)?

As of Thu Jun 13 2024, market cap of Chemours Co-The is 3.81 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CC stock?

You can check CC's fair value in chart for subscribers.

What is the fair value of CC stock?

You can check CC's fair value in chart for subscribers. The fair value of Chemours Co-The is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Chemours Co-The is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Chemours Co-The a good stock to buy?

The fair value guage provides a quick view whether CC is over valued or under valued. Whether Chemours Co-The is cheap or expensive depends on the assumptions which impact Chemours Co-The's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CC.

What is Chemours Co-The's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Jun 13 2024, CC's PE ratio (Price to Earnings) is -11.53 and Price to Sales (PS) ratio is 0.65. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CC PE ratio will change depending on the future growth rate expectations of investors.